| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 535.40M | 513.40M | 465.30M | 385.70M | 271.40M |
| Gross Profit | 203.90M | 513.40M | 167.10M | 135.00M | 81.10M |
| EBITDA | 166.80M | 152.20M | 129.40M | 104.90M | 74.50M |
| Net Income | 37.10M | 35.60M | 27.30M | 29.00M | 6.60M |
Balance Sheet | |||||
| Total Assets | 579.50M | 562.30M | 509.00M | 433.50M | 412.90M |
| Cash, Cash Equivalents and Short-Term Investments | 11.00M | 11.50M | 9.60M | 6.10M | 5.20M |
| Total Debt | 170.20M | 127.10M | 114.50M | 54.10M | 65.30M |
| Total Liabilities | 304.40M | 255.40M | 229.90M | 148.90M | 140.50M |
| Stockholders Equity | 275.10M | 306.90M | 279.10M | 284.60M | 272.40M |
Cash Flow | |||||
| Free Cash Flow | 38.30M | 91.20M | 28.40M | 18.30M | -21.60M |
| Operating Cash Flow | 139.90M | 141.80M | 121.40M | 94.50M | 44.60M |
| Investing Cash Flow | -103.00M | -130.70M | -119.20M | -71.60M | -66.90M |
| Financing Cash Flow | -37.50M | -9.50M | -2.10M | -17.70M | 11.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.86B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
76 Outperform | £2.18B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £11.96B | 31.67 | 6.51% | 1.68% | -1.58% | -34.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £489.54M | 14.60 | 13.04% | 3.18% | 6.55% | 18.44% | |
42 Neutral | £1.73B | 126.90 | ― | 0.36% | -2.24% | ― | |
41 Neutral | £329.87M | -2.81 | -142.88% | ― | -4.87% | ― |